Evogene Signals Possible U.S. Listing as Israel ‘Not Enough’

Evogene Ltd., which uses plant genomics to develop products for the agriculture and biofuel industries, is weighing additional listings as the company seeks to draw investors from abroad.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.